Mruk-Med I Sp. z o.o.
Rzeszów, Podkarpackie Voivodeship 35-021
0 studies enrolling now · 1 studies all time
What they study most
Adjuvant, EGFR, Early Stage Lung Cancer, Exon 20, Lung Cancer, NSCLC, Stage IB-IIIA, Post-surgical, Uncommon EGFR Mutations